APO Research
Talk to an analyst

APO RESEARCH · REPORT

Measles Combined with Live Attenuated Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Measles Combined with Live Attenuated Vaccine Industry Growth and Trends Forecast to 2032

29 December 202570 pages

Choose your research edition.

Industry ResearchMeasles Combined with Live Attenuated Vaccine Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Measles Combined with Live Attenuated Vaccine Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Measles Combined with Live Attenuated Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Measles Combined with Live Attenuated Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Measles Combined with Live Attenuated Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Measles Combined with Live Attenuated Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Measles Combined with Live Attenuated Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Measles Combined with Live Attenuated Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Measles Combined with Live Attenuated Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Measles Combined with Live Attenuated Vaccine include GSK, Shanghai Institute of Biological Products Co., Ltd, Merck and Beijing Institute of Biological Products Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Measles Combined with Live Attenuated Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Measles Combined with Live Attenuated Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Measles Combined with Live Attenuated Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Measles Combined with Live Attenuated Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Measles Combined with Live Attenuated Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Measles Combined with Live Attenuated Vaccine Market by Company

GSK

Shanghai Institute of Biological Products Co., Ltd

Merck

Beijing Institute of Biological Products Co., Ltd

Measles Combined with Live Attenuated Vaccine Segment by Type

Liquid

Powder

Measles Combined with Live Attenuated Vaccine Segment by Application

Hospital

Clinic

Measles Combined with Live Attenuated Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Measles Combined with Live Attenuated Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Measles Combined with Live Attenuated Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Measles Combined with Live Attenuated Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Measles Combined with Live Attenuated Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Measles Combined with Live Attenuated Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Liquid Table 2. Major Company of Powder Table 3. Global Measles Combined with Live Attenuated Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Measles Combined with Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Measles Combined with Live Attenuated Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Measles Combined with Live Attenuated Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Measles Combined with Live Attenuated Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Measles Combined with Live Attenuated Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Measles Combined with Live Attenuated Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Measles Combined with Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Measles Combined with Live Attenuated Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Measles Combined with Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Measles Combined with Live Attenuated Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Measles Combined with Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Measles Combined with Live Attenuated Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Measles Combined with Live Attenuated Vaccine Industry Trends Table 25. Measles Combined with Live Attenuated Vaccine Industry Drivers Table 26. Measles Combined with Live Attenuated Vaccine Industry Opportunities and Challenges Table 27. Measles Combined with Live Attenuated Vaccine Industry Restraints Table 28. Global Measles Combined with Live Attenuated Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Measles Combined with Live Attenuated Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Measles Combined with Live Attenuated Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Measles Combined with Live Attenuated Vaccine Sales Share by Company (2021-2026) Table 32. Global Measles Combined with Live Attenuated Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Measles Combined with Live Attenuated Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Measles Combined with Live Attenuated Vaccine Major Company Production Sites and Headquarters Table 35. Global Measles Combined with Live Attenuated Vaccine Company, Product Type & Application Table 36. Global Measles Combined with Live Attenuated Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Measles Combined with Live Attenuated Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Measles Combined with Live Attenuated Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Measles Combined with Live Attenuated Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Measles Combined with Live Attenuated Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Measles Combined with Live Attenuated Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Measles Combined with Live Attenuated Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Measles Combined with Live Attenuated Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Measles Combined with Live Attenuated Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Measles Combined with Live Attenuated Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Measles Combined with Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Measles Combined with Live Attenuated Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Measles Combined with Live Attenuated Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Measles Combined with Live Attenuated Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Measles Combined with Live Attenuated Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Measles Combined with Live Attenuated Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Measles Combined with Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Measles Combined with Live Attenuated Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Measles Combined with Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Measles Combined with Live Attenuated Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Measles Combined with Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Measles Combined with Live Attenuated Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Measles Combined with Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. GSK Measles Combined with Live Attenuated Vaccine Product Portfolio Table 75. GSK Recent Development Table 76. Shanghai Institute of Biological Products Co., Ltd Company Information Table 77. Shanghai Institute of Biological Products Co., Ltd Business Overview Table 78. Shanghai Institute of Biological Products Co., Ltd Measles Combined with Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Shanghai Institute of Biological Products Co., Ltd Measles Combined with Live Attenuated Vaccine Product Portfolio Table 80. Shanghai Institute of Biological Products Co., Ltd Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Measles Combined with Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merck Measles Combined with Live Attenuated Vaccine Product Portfolio Table 85. Merck Recent Development Table 86. Beijing Institute of Biological Products Co., Ltd Company Information Table 87. Beijing Institute of Biological Products Co., Ltd Business Overview Table 88. Beijing Institute of Biological Products Co., Ltd Measles Combined with Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Beijing Institute of Biological Products Co., Ltd Measles Combined with Live Attenuated Vaccine Product Portfolio Table 90. Beijing Institute of Biological Products Co., Ltd Recent Development Table 91. North America Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America Measles Combined with Live Attenuated Vaccine Sales by Country (2021-2026) & (K Units) Table 93. North America Measles Combined with Live Attenuated Vaccine Sales Market Share by Country (2021-2026) Table 94. North America Measles Combined with Live Attenuated Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America Measles Combined with Live Attenuated Vaccine Sales Market Share Forecast by Country (2027-2032) Table 96. North America Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Measles Combined with Live Attenuated Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Measles Combined with Live Attenuated Vaccine Market Share by Country (2021-2026) Table 99. North America Measles Combined with Live Attenuated Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Measles Combined with Live Attenuated Vaccine Market Share Forecast by Country (2027-2032) Table 101. Europe Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe Measles Combined with Live Attenuated Vaccine Sales by Country (2021-2026) & (K Units) Table 103. Europe Measles Combined with Live Attenuated Vaccine Sales Market Share by Country (2021-2026) Table 104. Europe Measles Combined with Live Attenuated Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe Measles Combined with Live Attenuated Vaccine Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Measles Combined with Live Attenuated Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Measles Combined with Live Attenuated Vaccine Market Share by Country (2021-2026) Table 109. Europe Measles Combined with Live Attenuated Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Measles Combined with Live Attenuated Vaccine Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Share by Country (2021-2026) Table 119. Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Share Forecast by Country (2027-2032) Table 121. Latin America Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America Measles Combined with Live Attenuated Vaccine Sales by Country (2021-2026) & (K Units) Table 123. Latin America Measles Combined with Live Attenuated Vaccine Sales Market Share by Country (2021-2026) Table 124. Latin America Measles Combined with Live Attenuated Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America Measles Combined with Live Attenuated Vaccine Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Measles Combined with Live Attenuated Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Measles Combined with Live Attenuated Vaccine Market Share by Country (2021-2026) Table 129. Latin America Measles Combined with Live Attenuated Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Measles Combined with Live Attenuated Vaccine Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Measles Combined with Live Attenuated Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Measles Combined with Live Attenuated Vaccine Market Share by Country (2021-2026) Table 139. Middle East and Africa Measles Combined with Live Attenuated Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Measles Combined with Live Attenuated Vaccine Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Measles Combined with Live Attenuated Vaccine Distributors List Table 144. Measles Combined with Live Attenuated Vaccine Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Measles Combined with Live Attenuated Vaccine Image Figure 2. Global Measles Combined with Live Attenuated Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Measles Combined with Live Attenuated Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Measles Combined with Live Attenuated Vaccine Sales (2021-2032) & (K Units) Figure 5. Liquid Image Figure 6. Global Liquid Sales YoY Growth (2021-2032) & (K Units) Figure 7. Powder Image Figure 8. Global Powder Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Measles Combined with Live Attenuated Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Measles Combined with Live Attenuated Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Measles Combined with Live Attenuated Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Measles Combined with Live Attenuated Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Measles Combined with Live Attenuated Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Measles Combined with Live Attenuated Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Measles Combined with Live Attenuated Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Measles Combined with Live Attenuated Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Measles Combined with Live Attenuated Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Measles Combined with Live Attenuated Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Measles Combined with Live Attenuated Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Measles Combined with Live Attenuated Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Measles Combined with Live Attenuated Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Measles Combined with Live Attenuated Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Measles Combined with Live Attenuated Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Measles Combined with Live Attenuated Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Measles Combined with Live Attenuated Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Measles Combined with Live Attenuated Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Measles Combined with Live Attenuated Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Measles Combined with Live Attenuated Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Measles Combined with Live Attenuated Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Powder
Applications
  • Hospital
  • Clinic
Companies covered
  • GSK
  • Shanghai Institute of Biological Products Co., Ltd
  • Merck
  • Beijing Institute of Biological Products Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Measles Combined with Live Attenuated Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Measles Combined with Live Attenuated Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Measles Combined with Live Attenuated Vaccine Market by Type
  6. 1.3.1 Liquid
  7. 1.3.2 Powder
  8. 1.4 Global Measles Combined with Live Attenuated Vaccine Market Size by Type
  9. 1.4.1 Global Measles Combined with Live Attenuated Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Measles Combined with Live Attenuated Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Measles Combined with Live Attenuated Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Measles Combined with Live Attenuated Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Measles Combined with Live Attenuated Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Measles Combined with Live Attenuated Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Measles Combined with Live Attenuated Vaccine Industry Trends
  2. 2.2 Measles Combined with Live Attenuated Vaccine Industry Drivers
  3. 2.3 Measles Combined with Live Attenuated Vaccine Industry Opportunities and Challenges
  4. 2.4 Measles Combined with Live Attenuated Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Measles Combined with Live Attenuated Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Measles Combined with Live Attenuated Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Measles Combined with Live Attenuated Vaccine Price (2021-2026)
  4. 3.4 Global Measles Combined with Live Attenuated Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Measles Combined with Live Attenuated Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Measles Combined with Live Attenuated Vaccine Company, Product Type & Application
  7. 3.7 Global Measles Combined with Live Attenuated Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Measles Combined with Live Attenuated Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Measles Combined with Live Attenuated Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Measles Combined with Live Attenuated Vaccine Tier 1, Tier 2, and Tier 3
4 Measles Combined with Live Attenuated Vaccine Regional Status and Outlook
  1. 4.1 Global Measles Combined with Live Attenuated Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Measles Combined with Live Attenuated Vaccine Historic Market Size by Region
  3. 4.2.1 Global Measles Combined with Live Attenuated Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Measles Combined with Live Attenuated Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Measles Combined with Live Attenuated Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Measles Combined with Live Attenuated Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Measles Combined with Live Attenuated Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Measles Combined with Live Attenuated Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Measles Combined with Live Attenuated Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Measles Combined with Live Attenuated Vaccine by Application
  1. 5.1 Measles Combined with Live Attenuated Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Measles Combined with Live Attenuated Vaccine Market Size by Application
  5. 5.2.1 Global Measles Combined with Live Attenuated Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Measles Combined with Live Attenuated Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Measles Combined with Live Attenuated Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Measles Combined with Live Attenuated Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Measles Combined with Live Attenuated Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Measles Combined with Live Attenuated Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Measles Combined with Live Attenuated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Measles Combined with Live Attenuated Vaccine Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Shanghai Institute of Biological Products Co., Ltd
  8. 6.2.1 Shanghai Institute of Biological Products Co., Ltd Company Information
  9. 6.2.2 Shanghai Institute of Biological Products Co., Ltd Business Overview
  10. 6.2.3 Shanghai Institute of Biological Products Co., Ltd Measles Combined with Live Attenuated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai Institute of Biological Products Co., Ltd Measles Combined with Live Attenuated Vaccine Product Portfolio
  12. 6.2.5 Shanghai Institute of Biological Products Co., Ltd Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Measles Combined with Live Attenuated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Measles Combined with Live Attenuated Vaccine Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Beijing Institute of Biological Products Co., Ltd
  20. 6.4.1 Beijing Institute of Biological Products Co., Ltd Company Information
  21. 6.4.2 Beijing Institute of Biological Products Co., Ltd Business Overview
  22. 6.4.3 Beijing Institute of Biological Products Co., Ltd Measles Combined with Live Attenuated Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Beijing Institute of Biological Products Co., Ltd Measles Combined with Live Attenuated Vaccine Product Portfolio
  24. 6.4.5 Beijing Institute of Biological Products Co., Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Measles Combined with Live Attenuated Vaccine Sales by Country
  2. 7.1.1 North America Measles Combined with Live Attenuated Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Measles Combined with Live Attenuated Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Measles Combined with Live Attenuated Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Measles Combined with Live Attenuated Vaccine Market Size by Country
  6. 7.2.1 North America Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Measles Combined with Live Attenuated Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Measles Combined with Live Attenuated Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Measles Combined with Live Attenuated Vaccine Sales by Country
  2. 8.1.1 Europe Measles Combined with Live Attenuated Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Measles Combined with Live Attenuated Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Measles Combined with Live Attenuated Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Measles Combined with Live Attenuated Vaccine Market Size by Country
  6. 8.2.1 Europe Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Measles Combined with Live Attenuated Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Measles Combined with Live Attenuated Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Measles Combined with Live Attenuated Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Measles Combined with Live Attenuated Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Measles Combined with Live Attenuated Vaccine Sales by Country
  2. 10.1.1 South America Measles Combined with Live Attenuated Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Measles Combined with Live Attenuated Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Measles Combined with Live Attenuated Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Measles Combined with Live Attenuated Vaccine Market Size by Country
  6. 10.2.1 South America Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Measles Combined with Live Attenuated Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Measles Combined with Live Attenuated Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Measles Combined with Live Attenuated Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Measles Combined with Live Attenuated Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Measles Combined with Live Attenuated Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Measles Combined with Live Attenuated Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Measles Combined with Live Attenuated Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Measles Combined with Live Attenuated Vaccine Value Chain Analysis
  2. 12.1.1 Measles Combined with Live Attenuated Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Measles Combined with Live Attenuated Vaccine Production Mode & Process
  7. 12.2 Measles Combined with Live Attenuated Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Measles Combined with Live Attenuated Vaccine Distributors
  10. 12.2.3 Measles Combined with Live Attenuated Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst